Short interest in Galectin Therapeutics Inc (NASDAQ:GALT) increased during the last reporting period, rising from 3.95M to 4.01M. This put 13.44% of the company's publicly available shares short.

Short interest for Galectin Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Galectin Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 413.70K shares traded per day, it would take 9.69 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.